Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Coffee's Neuroprotective Effects Supported

People who drink several cups of coffee every day may have a decreased risk of developing multiple sclerosis (MS).

Cinnamon: A Future Treatment for MS?

Cinnamon has shown promise in helping diabetes patients with blood glucose control and in treatment of polycystic ovary syndrome (PCOS), and now the spice could one day benefit patients with multiple sclerosis (MS).

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

New Data on Qudexy XR

Upsher-Smith announced the results of a year-long, open-label extension study of the safety and efficacy of Qudexy XR (topiramate) extended-release capsules as adjunctive therapy in patients with refractory partial-onset seizures (POS).

People with Dementia Often Not Screened

More than half of Americans with dementia have never undergone screening of their cognitive function.

Parkinson's Meds May Spur Compulsive Behaviors

Medications commonly used to treat Parkinson's disease may raise the risk of impulse control disorders such as compulsive gambling, compulsive shopping, and/or hypersexuality.

No Link Between Vaccines, Multiple Sclerosis

There is no link between vaccines and increased risk of multiple sclerosis or other acquired central nervous system demyelinating syndromes, according to a recent study.

Can Cocoa Improve Memory Loss?

A lab-created cocoa drink appears to improve normal age-related memory loss, according to a small new study.


Heart Function Could Indicate Alzheimer's Dementia Risk

Heart function could be a major risk factor for dementia and Alzheimer's disease, report researchers at Vanderbilt University Medical Center in a new study published in the journal Circulation.

Cerebral Blood Flow Could Assist Concussion Prognosis

Scans show reduced circulation in football players who had not recovered from injury

Overactive Bladder Drug May be Beneficial in MS

Researchers from the University of Buffalo have found a way to improve remyelination for myelin-based diseases like multiple sclerosis (MS).

FDA to Review Investigational Parkinson's Disease Drug Xadago

The FDA has accepted for filing the New Drug Application (NDA) for Xadago (safinamide; Newron and Zambon) as add-on therapy in both early and mid-to-late stage Parkinson's disease (PD) patients who are inadequately managed on their current treatment.


Is Roseroot a Reliable Alternative for Nervous System Ailments?

Is Roseroot a Reliable Alternative for Nervous System Ailments?

The perennial plant has been used to treat depression, muscle weakness and muscle fatigue.

Treating Traumatic Brain Injury in Young Athletes

Treating Traumatic Brain Injury in Young Athletes

Accurate identification, assessment and evaluation of concussions will enable clinicians to determine when it is safe for young athletes to return to competition.

Drug Therapies for Restless Legs Syndrome

Drug Therapies for Restless Legs Syndrome

Willis-Ekbom disease, otherwise known as restless legs syndrome, is a neurologic disorder that affects up to 10% of Americans. Individuals with RLS develop irresistible urges to move their legs accompanied by unusual or unpleasant sensations in the legs.

Featured courses from mycme

Comprehensive Review of Electrodiagnostic Medicine and Neuromuscular DisordersExternal web site

Led by Program Directors Anthony A. Amato, MD, and William S. David, MD, PhD, authoritative ...

CME 31.50 Credits

UCLA Review of Clinical NeurologyExternal web site

Led by Course Chair Alon Avidan, MD, MPH, the authoritative faculty of The UCLA Review ...

CME 23.00 Credits

Musculoskeletal, Neurologic, Psych/Behavioral ScienceExternal web site

This module reviews all topics on the NCCPA examination blueprint relating to the Musculoskeletal, Neurologic, ...

CME 5.25 Credits

Sign Up for Free e-newsletters